Today: 5 April 2026
Browse Category

Earnings Reports 6 February 2026

Qualys stock slides nearly 13% after Q4 beat as 2026 outlook cools the mood

Qualys stock slides nearly 13% after Q4 beat as 2026 outlook cools the mood

Qualys shares dropped 12.7% to $111.62 Friday after the company forecast 2026 revenue growth of 7% to 8%, below last year’s 10%. The cybersecurity firm reported fourth-quarter revenue of $175.3 million and raised its share buyback program by $200 million. RBC and Truist trimmed price targets. CEO Sumedh Thakar received performance shares, with some withheld for taxes.
Cisco stock pops near a fresh high as UBS sticks with Buy ahead of Feb. 11 earnings

Cisco stock pops near a fresh high as UBS sticks with Buy ahead of Feb. 11 earnings

Cisco shares rose 2.4% to $84.32 Friday, nearing a record high ahead of its Feb. 11 earnings report. UBS reaffirmed its Buy rating and $90 target, citing stable enterprise demand and expected revenue above $15.05 billion. Investors are watching for updates on AI-driven orders and network spending. The earnings release coincides with key U.S. jobs and inflation data.
ALGN stock jumps again as Align Technology rides Invisalign earnings beat and fresh analyst targets

ALGN stock jumps again as Align Technology rides Invisalign earnings beat and fresh analyst targets

Align Technology shares rose about 4% to $182.70 by midday Friday, following a strong earnings report and record clear-aligner shipments. The company posted Q4 revenue of $1.05 billion and non-GAAP earnings of $3.29 per share, with 676,900 cases shipped. Align forecast Q1 revenue between $1.01 billion and $1.03 billion. The stock jumped 11% in the previous session.
AbbVie stock rises as investors re-rank Rinvoq and Skyrizi after earnings jolt

AbbVie stock rises as investors re-rank Rinvoq and Skyrizi after earnings jolt

AbbVie shares climbed 2% to $223.45 in midday trading Friday after a volatile week. The move followed a quarterly report showing fourth-quarter net revenues up 10% to $16.62 billion and adjusted profit of $2.71 per share. Humira sales dropped 25.9% as biosimilar competition increased, while Skyrizi and Rinvoq posted gains. The company also announced new regulatory approvals and licensing deals.
Applied Materials stock jumps nearly 6% as Citi lifts target to $400, eyes turn to Feb. 12 earnings

Applied Materials stock jumps nearly 6% as Citi lifts target to $400, eyes turn to Feb. 12 earnings

Applied Materials shares rose 5.7% to $321.20 by midday after Citi raised its price target to $400 and kept a Buy rating ahead of the Feb. 12 earnings report. Traders are focused on guidance for chip-factory investment and demand from China. Peers Lam Research and KLA also posted strong gains.
IREN stock price whipsaws after Q2 miss as Microsoft GPU financing takes center stage

IREN stock price whipsaws after Q2 miss as Microsoft GPU financing takes center stage

IREN shares surged nearly 7% to $42.64 Friday after plunging 11% on a quarterly revenue miss. The bitcoin miner reported a $155.4 million net loss and $184.7 million revenue for the quarter, down from the previous period. IREN announced $3.6 billion in GPU financing tied to a Microsoft deal and plans for a new Oklahoma data center. Most revenue remains linked to crypto, despite the AI cloud pivot.
Salesforce stock tries to stabilize after AI “software-mageddon” — Feb. 25 earnings is the next test

Salesforce stock tries to stabilize after AI “software-mageddon” — Feb. 25 earnings is the next test

Salesforce shares rose 0.1% to $190.07 Friday after a volatile week, but remain down 9% since Monday. The S&P 500 software and services index fell 4.6% Thursday, erasing about $1 trillion in market value since Jan. 28. Investors are concerned rapid AI adoption could disrupt traditional software revenue models. Salesforce reports earnings Feb. 25.
Sirius XM stock drops after earnings pop fades as traders weigh 2026 cash-flow target

Sirius XM stock drops after earnings pop fades as traders weigh 2026 cash-flow target

Sirius XM shares fell 5.3% to $21.40 Friday after Seaport Global downgraded the stock, erasing part of Thursday’s 9% surge. The company set 2026 targets of $8.5 billion in revenue and $2.6 billion adjusted EBITDA, but subscriber losses and concerns over pricing weighed on sentiment. SiriusXM ended 2025 with 33 million subscribers and reported $8.56 billion in revenue for the year.
Hershey stock price jumps again: HSY extends rally as 2026 outlook tops estimates

Hershey stock price jumps again: HSY extends rally as 2026 outlook tops estimates

Hershey shares rose about 3% Friday, extending gains after a strong fourth-quarter report and a 2026 outlook that topped analyst forecasts. The stock peaked at $234.01 before settling near $231.10 in morning trading. The company projected 2026 net sales growth of 4–5% and adjusted EPS of $8.20–$8.52. Hershey expects first-quarter margins to remain pressured, with improvement likely in the second quarter.
ITT stock rises again after earnings jump; KeyBanc lifts target to $230

ITT stock rises again after earnings jump; KeyBanc lifts target to $230

ITT shares rose 0.9% to $203.82 Friday after a 9% rally Thursday, driven by strong Q4 results and a raised dividend. The company reported a 13% revenue jump to $1.054 billion and set Q1 EPS guidance at $1.67–$1.71. ITT expects to close its SPX Flow acquisition in March and will adjust profit metrics after the deal. KeyBanc raised its price target to $230.
Dauch (DCH) stock slips as Feb. 13 earnings date nears after Dowlais deal

Dauch (DCH) stock slips as Feb. 13 earnings date nears after Dowlais deal

Dauch Corp shares fell 0.7% to $8.15 in early New York trading after the company set Feb. 13 for its first earnings report since switching to the DCH ticker. The board added two former Dowlais directors as integration efforts began. Dauch confirmed new share issuance and dual listing in London tied to the Dowlais deal. The stock traded between $8.13 and $8.44 Friday, within a 52-week range of $3.00 to $9.25.
6 February 2026
Cardinal Health stock today: CAH slips in early trade after forecast hike

Cardinal Health stock today: CAH slips in early trade after forecast hike

Cardinal Health shares fell 0.2% to $226.66 Friday morning, despite raising its fiscal 2026 adjusted earnings forecast to $10.15-$10.35 per share after beating quarterly estimates. Second-quarter revenue rose 19% to $65.6 billion, with adjusted EPS at $2.63. CEO Jason Hollar cited strong specialty medicine demand but downplayed obesity drugs’ profit impact. Cencora rose 0.9%, McKesson slipped 0.4%.
Robinhood stock snaps back as HOOD heads into earnings after a rough week

Robinhood stock snaps back as HOOD heads into earnings after a rough week

Robinhood shares rose about 13% Friday after a 50% drop since October, ahead of its February 10 earnings report. The stock remains down nearly 30% year-to-date amid tech sector volatility and concerns over AI automation. Zacks noted HOOD is now technically oversold and trading at its lowest RSI point. Robinhood has expanded into new business lines and reported growth in paid subscribers and revenue per user.
Liberty Global stock price jolts as rarely traded LBTYB jumps; LBTYA ticks up into earnings

Liberty Global stock price jolts as rarely traded LBTYB jumps; LBTYA ticks up into earnings

Liberty Global’s Class B shares (LBTYB) surged 86% Friday, peaking at $51.24 before closing at $22.40 on heavy volume, with no new filings or news. Class A and C shares both rose 1.4% to $11.42. The company will report full-year results on February 18. Liberty Global and Telefonica are also preparing a £2 billion bid for UK broadband provider Netomnia, according to the Financial Times.
Kulicke & Soffa stock price today: KLIC steadies premarket after 19% earnings jump, Needham lifts target

Kulicke & Soffa stock price today: KLIC steadies premarket after 19% earnings jump, Needham lifts target

Kulicke & Soffa shares rose 0.4% to $66.66 in premarket trading Friday after a 19.3% surge Thursday, following upbeat Q2 revenue guidance of around $230 million. Fiscal Q1 net revenue reached $199.6 million, with utilization rates topping 80% in general semiconductors. Needham raised its price target to $70. The company filed its latest 10-Q on Thursday.
1 28 29 30 31 32 229

Stock Market Today

  • Evertec Inc (EVTC) Shares Show Mixed Performance Amid Valuation Discount
    April 5, 2026, 1:09 PM EDT. Evertec Inc (EVTC) stock has delivered mixed returns recently, with short-term gains contrasting longer-term losses, including a 16.62% decline over the past year. Trading at $28.07, the shares are priced below a fair value estimate of $32.60, signaling a potential 13.9% undervaluation based on earnings and cash flow forecasts. The company's ongoing technology upgrades, integration of acquisitions in Latin America, and contract repricing aim to boost margins and free cash flow, underpinning multi-year growth. However, risks include large customer contracts and currency fluctuations. EVTC's current price-to-earnings (P/E) ratio of 12.2x sits below peer averages, suggesting cautious market sentiment despite its discount. Investors should weigh these factors when considering potential upside or risks in EVTC shares.
Go toTop